Remedy Entertainment Oyj Future Growth
Future criteria checks 5/6
Remedy Entertainment Oyj is forecast to grow earnings and revenue by 84.5% and 23% per annum respectively. EPS is expected to grow by 91.6% per annum. Return on equity is forecast to be 4.8% in 3 years.
Key information
84.5%
Earnings growth rate
91.6%
EPS growth rate
| Entertainment earnings growth | 21.5% |
| Revenue growth rate | 23.0% |
| Future return on equity | 4.8% |
| Analyst coverage | Low |
| Last updated | 03 Apr 2024 |
Recent future growth updates
Recent updates
Analyst Forecasts Just Got A Lot More Bearish On Remedy Entertainment Oyj (HEL:REMEDY)
Feb 20
Health Check: How Prudently Does Remedy Entertainment Oyj (HEL:REMEDY) Use Debt?
Oct 27Calculating The Intrinsic Value Of Remedy Entertainment Oyj (HEL:REMEDY)
Sep 15Does Remedy Entertainment Oyj (HEL:REMEDY) Have A Healthy Balance Sheet?
Apr 05Remedy Entertainment Oyj (HEL:REMEDY) Just Reported And Analysts Have Been Cutting Their Estimates
Feb 15The Returns On Capital At Remedy Entertainment Oyj (HEL:REMEDY) Don't Inspire Confidence
Apr 29Remedy Entertainment Oyj (HEL:REMEDY) Has A Pretty Healthy Balance Sheet
Mar 07Remedy Entertainment Oyj (HEL:REMEDY) Shares Could Be 35% Below Their Intrinsic Value Estimate
Feb 16Investors Could Be Concerned With Remedy Entertainment Oyj's (HEL:REMEDY) Returns On Capital
Dec 30Do Remedy Entertainment Oyj's (HEL:REMEDY) Earnings Warrant Your Attention?
May 22Estimating The Intrinsic Value Of Remedy Entertainment Oyj (HEL:REMEDY)
May 04Investors Who Bought Remedy Entertainment Oyj (HEL:REMEDY) Shares Three Years Ago Are Now Up 557%
Mar 07Remedy Entertainment Oyj (HEL:REMEDY) Seems To Use Debt Rather Sparingly
Feb 16Should You Rely On Remedy Entertainment Oyj's (HEL:REMEDY) Earnings Growth?
Feb 04Calculating The Fair Value Of Remedy Entertainment Oyj (HEL:REMEDY)
Jan 19Under The Bonnet, Remedy Entertainment Oyj's (HEL:REMEDY) Returns Look Impressive
Jan 05
Is Now The Time To Put Remedy Entertainment Oyj (HEL:REMEDY) On Your Watchlist?
Dec 21Did You Miss Remedy Entertainment Oyj's (HEL:REMEDY) Whopping 388% Share Price Gain?
Dec 06Remedy Entertainment Oyj (HEL:REMEDY) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Nov 20Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 68 | 1 | -2 | 8 | 1 |
| 12/31/2025 | 68 | -3 | -10 | 3 | 2 |
| 12/31/2024 | 54 | -10 | -20 | -2 | 2 |
| 12/31/2023 | 34 | -23 | -23 | -16 | N/A |
| 9/30/2023 | 36 | -16 | -21 | -13 | N/A |
| 6/30/2023 | 37 | -9 | -19 | -9 | N/A |
| 3/31/2023 | 40 | -6 | -9 | 1 | N/A |
| 12/31/2022 | 44 | -2 | 0 | 11 | N/A |
| 9/30/2022 | 46 | 3 | 1 | 12 | N/A |
| 6/30/2022 | 49 | 7 | 2 | 12 | N/A |
| 3/31/2022 | 47 | 8 | -1 | 9 | N/A |
| 12/31/2021 | 45 | 9 | -4 | 6 | N/A |
| 9/30/2021 | 45 | 9 | 1 | 10 | N/A |
| 6/30/2021 | 45 | 9 | 6 | 14 | N/A |
| 3/31/2021 | 45 | 10 | 6 | 13 | N/A |
| 12/31/2020 | 46 | 10 | 5 | 12 | N/A |
| 9/30/2020 | 42 | 8 | 2 | 6 | N/A |
| 6/30/2020 | 38 | 7 | -2 | 1 | N/A |
| 3/31/2020 | 36 | 6 | -1 | 0 | N/A |
| 12/31/2019 | 33 | 5 | 0 | 0 | N/A |
| 9/30/2019 | 29 | 4 | 3 | 3 | N/A |
| 6/30/2019 | 25 | 2 | 7 | 7 | N/A |
| 3/31/2019 | 23 | 1 | 5 | 5 | N/A |
| 12/31/2018 | 20 | 1 | 2 | 2 | N/A |
| 6/30/2018 | 18 | 1 | -6 | -6 | N/A |
| 3/31/2018 | 18 | 1 | -4 | -4 | N/A |
| 12/31/2017 | 17 | 1 | -2 | -2 | N/A |
| 12/31/2016 | 16 | 3 | N/A | 6 | N/A |
| 12/31/2015 | 14 | 1 | N/A | 1 | N/A |
| 12/31/2014 | 12 | 2 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: REMEDY is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.9%).
Earnings vs Market: REMEDY is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: REMEDY is expected to become profitable in the next 3 years.
Revenue vs Market: REMEDY's revenue (23% per year) is forecast to grow faster than the Finnish market (1.9% per year).
High Growth Revenue: REMEDY's revenue (23% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: REMEDY's Return on Equity is forecast to be low in 3 years time (4.8%).